Lindsey Fauveau, MD
Surgical Oncology · Baton Rouge, LANPI 1548526031
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Intuitive Surgical at 45.0% of the total. Reporting peaked in 2019 at $2,096 and has fallen 95.4% since, to $96 in 2025.
Across 40 payments — averaging $111.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Stryker$1K
- Endomagnetics Ltd$748
- KUB Technologies Inc.$252
- Leica Microsystems Inc.$229
- W. L. Gore & Associates, Inc.$96
- plus $109 from 5 others
What the payments were for
- Travel & lodging$1,54335%
- Food & beverage$1,90843%
- Education$1,00022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $2,002 |
| Stryker | 11 | $1,015 |
| Endomagnetics Ltd | 11 | $748 |
| KUB Technologies Inc. | 1 | $252 |
| Leica Microsystems Inc. | 2 | $229 |
| W. L. Gore & Associates, Inc. | 1 | $96 |
| Merck | 1 | $33 |
| Innovation Technologies Inc | 1 | $28 |
| Cardinal Health 414 LLC | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Merit Medical Systems Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,450 in reported general payments places this provider in the 80th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 46 | $281 |
| Tramadol Hcl | 44 | $61 |
| Diazepam | 12 | $9 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Baton Rouge
- Peter BostickBaton Rouge$7K
- Jennifer PeroneBaton Rouge$3K
- Robert ElliottBaton Rouge$101
- Michael HaileyBaton Rouge$53
- Emery MinnardGretna$183K
- Mary Hobbs-MaluccioMetairie$41K
- Terry LairmoreShreveport$13K
- Nathan BoltonNew Orleans$6K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.